March Editors’ Picks from AACR Journals
Back for March are the editors’ picks from the portfolio of scientific journals published by the American Association for...
Back for March are the editors’ picks from the portfolio of scientific journals published by the American Association for...
Last week saw a flurry of new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) for...
For the first Editors’ Picks collection of 2022, the editors of the AACR journals highlighted studies that assessed the...
Early detection of cancer is arguably a holy grail in the field of cancer research. Catching the disease at...
Guest post by Raymond N. DuBois, MD, PhD, FAACR The headlines stunned many medical professionals, cancer patients, and colorectal...
Prevention is often said to be more powerful than a cure. With an eye toward thwarting the disease, some...
As the first AACR Annual Meeting held in person after the pandemic was coming to a close, the last...
Over the course of AACR Annual Meeting 2019, there were 213 presentations on incredibly exciting clinical trials. This is...
In follow up to the AACR Cancer Progress Report 2014, AACR President Carlos L. Arteaga, MD, discusses our continuing...
With warm weather finally here, bringing more people outdoors, it is important to remember that many cases of skin...
During late March and early April, the U.S. Food and Drug Administration (FDA) made several decisions that have increased...
Learn about cancer vaccines, including the various types used to treat or prevent cancer, and discover what's on the...
2020 was filled with unexpected challenges for cancer research and patient care. As many of us shifted our lives...
January is Cervical Cancer Awareness Month. It’s a time to celebrate progress against a disease that was once a...
New research improves physicians' “molecular chess” game against thyroid cancer to overcome resistance to treatments.
The editors of the 10 AACR journals have selected a handful of must-read articles from the July issues. The...
Just before the holidays, the U.S. Food and Drug Administration (FDA) had good news for the ovarian cancer research...
By Steven Grossman, MD, PhD Pancreatic cancer is an outlier among cancers, fiercely resisting almost every scientific advance researchers...
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
In the global battle against the COVID-19 pandemic, cancer researchers are proving to be formidable forces. Armed with deep...
In recent years, the U.S. Food and Drug Administration has approved immune checkpoint inhibitors, a class of immunotherapy, to...
The AACR Annual Meeting 2019 features the theme “Integrative Cancer Science • Global Impact • Individualized Patient Care.” That theme provided...
Researchers around the world are designing and implementing methods to increase access to cancer care in low-resource areas.
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today In his 2016 State of the Union address, President...
Last week, more than 100 patients, survivors, family members, advocates, and researchers came together for a symposium at the...
Guest Post by Kevin McLaughlin Executive Editor, Cancer Today When my father was diagnosed with prostate cancer, alarm bells sounded...
Rare cancers, when taken all together, make up an estimated 20 to 25 percent of all cancers diagnosed. With...
Earlier this month, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the...
Cancer prevention refers to measures that people can take to reduce their risk of developing cancer. These measures can...
As we learned recently, Senator John McCain was diagnosed with glioblastoma multiforme, an aggressive form of central nervous system...